Duprez, D. A., Handelsman, Y., & Koren, M. (2020). Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects. Vasc Health Risk Manag.
Citação norma ChicagoDuprez, Daniel A., Yehuda Handelsman, and Michael Koren. "Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects." Vasc Health Risk Manag 2020.
Citação norma MLADuprez, Daniel A., Yehuda Handelsman, and Michael Koren. "Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects." Vasc Health Risk Manag 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.